National Health Investors, Inc. (NHI)
| Market Cap | 3.49B -5.2% |
| Revenue (ttm) | 435.78M +25.0% |
| Net Income | 166.53M +16.7% |
| EPS | 3.46 +10.4% |
| Shares Out | 49.11M |
| PE Ratio | 20.50 |
| Forward PE | 20.17 |
| Dividend | $3.76 (5.29%) |
| Ex-Dividend Date | Sep 30, 2026 |
| Volume | 81,313 |
| Open | 70.82 |
| Previous Close | 70.88 |
| Day's Range | 70.76 - 71.50 |
| 52-Week Range | 67.94 - 91.38 |
| Beta | 0.55 |
| Analysts | Buy |
| Price Target | 82.13 (+15.71%) |
| Earnings Date | Aug 10, 2026 |
About NHI
National Health Investors, Inc. is a self-managed real estate investment trust (REIT). The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing on senior housing communities and medical facilities. The Company operates through two reportable segments, Real Estate Investments and SHOP. The Company’s real estate property investments include independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilit... [Read more]
Financial Performance
In 2025, National Health Investors's revenue was $379.29 million, an increase of 13.02% compared to the previous year's $335.58 million. Earnings were $141.98 million, an increase of 2.98%.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for NHI stock is "Buy." The 12-month stock price target is $82.13, which is an increase of 15.71% from the latest price.
News
National Health Investors price target lowered to $80 from $81 at Truist
Truist lowered the firm’s price target on National Health Investors (NHI) to $80 from $81 and keeps a Buy rating on the shares. The firm is updating its model after…
National Health Investors price target lowered to $78 from $79 at Wells Fargo
Wells Fargo lowered the firm’s price target on National Health Investors (NHI) to $78 from $79 and keeps an Equal Weight rating on the shares. The firm believes REITs will…
National Health Investors price target lowered to $86 from $91 at BofA
BofA analyst Farrell Granath lowered the firm’s price target on National Health Investors (NHI) to $86 from $91 and keeps a Buy rating on the shares. The firm updated its…
National Health Investors management to meet with Cantor Fitzgerald
Meeting to be held in New York on August 13 hosted by Cantor Fitzgerald.
National Health Investors Earnings Call Transcript: Q2 2026
Second quarter results were driven by the NHC portfolio sale, strong SHOP platform growth, and disciplined capital allocation. Net income per share rose 45.6% year-over-year, and liquidity remains robust. Full-year guidance for SHOP NOI growth is unchanged, with a focus on reinvesting NHC proceeds.
National Health Investors Slides: Q2 2026
National Health Investors has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 11, 2026.
National Health Investors Quarterly report: Q2 2026
National Health Investors has published its Q2 2026 quarterly earnings report on August 11, 2026.
National Health Investors Earnings release: Q2 2026
National Health Investors released its Q2 2026 earnings on August 11, 2026, summarizing the period's financial results.
National Health Investors reports Q2 normalized FFO $1.19 , consensus $1.26
Reports Q2 revenue $121.32M, consensus $112.51M. “We continued to expand our Senior Housing Operating Portfolio with Q2 invested capital of $854.8M, a 137% increase from the prior year period,” said…
National Health Investors sees FY26 normalized FFO $4.74-$4.7, consensus $4.87
The Company’s FY26 guidance includes the following assumptions: $180M in unidentified new investments; approximately $665M in expected proceeds from dispositions resulting in a gain ranging between $5...
NHI Issues Investor Update
MURFREESBORO, Tenn., Aug. 10, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) has issued the following investor update which can be found at: https://investors.nhireit.com/News/presen...
NHI Announces Second Quarter 2026 Results
MURFREESBORO, Tenn., Aug. 10, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) announced today its results for the quarter ended June 30, 2026.
National Health Investors appoints Chris Maingot as COO
National Health Investors (NHI) announced that it has appointed Chris Maingot as COO effective July 27. Prior to joining NHI, he served as CEO of Longview Senior Housing. Published first…
NHI Appoints Chris Maingot as Chief Operating Officer
MURFREESBORO, Tenn., July 27, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) announced today that it has appointed Chris Maingot as Chief Operating Officer effective July 27, 2026.
NHI Announces Second Quarter 2026 Earnings Release and Conference Call Dates
MURFREESBORO, Tenn., July 15, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) announced details for the release of its results for the second quarter ended June 30, 2026.
National Health Investors price target lowered to $80 from $85 at Deutsche Bank
Deutsche Bank analyst Omotayo Okusanya lowered the firm’s price target on National Health Investors (NHI) to $80 from $85 and keeps a Hold rating on the shares after hosting meetings…
Honeywell Aerospace Set to Join S&P 500 & S&P 100; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, June 23, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600: Honeywell Aerospace Inc. (NASD: HONA) will...
National Health Investors to replace Apollo Commercial in S&P 600 at open 6/30
Apollo Commercial (ARI) Real Estate Finance has announced ongoing liquidation activities and is no longer appropriate for the S&P SmallCap 600.
SailPoint Announces Intent to Acquire Entro to Accelerate and Enhance Agentic Fabric and Secure the Future of AI-Driven Enterprises
AUSTIN, Texas, June 15, 2026 (GLOBE NEWSWIRE) -- SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise identity security, today announced its intent to acquire Tel Aviv-based Entro, a pioneer in non-...
National Health Investors price target lowered to $80 from $90 at BMO Capital
BMO Capital lowered the firm’s price target on National Health Investors (NHI) to $80 from $90 and keeps an Outperform rating on the shares as part of a broader research…
National Health Investors price target lowered to $81 from $89 at Truist
Truist lowered the firm’s price target on National Health Investors (NHI) to $81 from $89 and keeps a Buy rating on the shares. The NHC outcome may not have lived…
National Health Investors Transcript: AGM 2026
The meeting highlighted strong 2025 financial results, including double-digit growth in NFFO and FAD per share, a raised dividend, and a strategic shift toward private pay senior housing. All directors were re-elected, executive compensation was approved, and BDO was ratified as auditor.
National Health Investors price target lowered to $91 from $97 at BofA
BofA lowered the firm’s price target on National Health Investors (NHI) to $91 from $97 and keeps a Buy rating on the shares. The firm updated its price targets on…
National Health Investors Earnings Call Transcript: Q1 2026
Q1 2026 results exceeded expectations with strong SHOP growth and a $560M NHC portfolio sale advancing capital recycling. Updated guidance reflects near-term earnings pressure but positions for long-term growth, with robust liquidity and a focus on private pay senior housing.
National Health Investors Quarterly report: Q1 2026
National Health Investors has published its Q1 2026 quarterly earnings report on May 5, 2026.